# | Age | Sex | Graft type date | Diagnostic | CMV Prophylaxis | Intervala months | CMV disease | Log CMV DNA change/1st week | Clearance of CMV viremia (Time to clearance) | Recurrence of CMV disease (time from end of therapy) | Immunosuppressive maintenance regimenb |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 64 | M | Liver | Cirrhosis Child C | VGCc | 8.9 | Colitis | -1.2 | Yes (34 days) | No | tacrolimus (10 μg/l)d |
19.02.2005 | Alpha-antitrypsin deficiency | 450 mg bid | (definite) | prednisone (7.5 qd) | |||||||
6 months | MMFe (stop for 1.5 months) | ||||||||||
2 | 53 | F | Cardiac | Idiopathic dilated | VGC | 6.2 | Colitis | -1.3 | No | No | cyclosporine (200 μg/l)d |
26.05.2005 | cardiomyopathy | 450 mg bid | (definite) | prednisone (10 mg qd) | |||||||
3 months | MMFe (1000 mg bid) | ||||||||||
3 | 46 | M | Kidney | Drug toxicity: | VGC | 24.5 | Syndrome | -1.8 | Yes (29 days) | No | tacrolimus (7 μg/l)d |
11.10.2004 | cisplatin, ifosfamide, contrast | 450 mg qd | (probable) | prednisone (5 mg qd) | |||||||
products, non steroidal analgesics | 3 months | MPSf (180 mg bid) | |||||||||
4 | 62 | M | Kidney | Hepatorenal polykystosis | VGC | 9.4 | Syndrome | -1.2 | No | Syndrome (probable) | tacrolimus (8 μg/l)d |
24.03.2006 | 450 mg qd | (probable) | (21 days) | prednisone (5 mg qd) | |||||||
3 months | Colitis (definite) (45 days) | MMFe (500 mg bid) | |||||||||
5 | 49 | M | Liver | Cirrhosis Child A | None | 1.4 | Asymptomatic | -0.8 | Yes (28 days) | No | cyclosporine (240 μg/l)d |
03.07.2007 | Hepatocellular carcinoma (HCV) | infection | prednisone (15 mg qd) | ||||||||
AZAg (150 mg qd) | |||||||||||
6 | 64 | M | Kidney | Hepatorenal polykystosis | VGC | 9.7 | Syndrome h | -0.8 | Yes (82 days) | No | tacrolimus (8 μg/l)d |
13.12.2006 | 450 mg qd | (probable) | prednisone (10 mg qd) | ||||||||
3 months | MMFe (750 mg bid) | ||||||||||
7 | 68 | M | Kidney | Hypertension | VGC | 4.4 | Syndrome | 0 | Yes (42 days) | Gastritis (definite) | tacrolimus (7 μg/l)d |
01.12.2006 | 450 mg qd | (probable) | (62 days) | prednisone (5 mg qd) | |||||||
3 months | MMFe (250 mg bid) |